Market Research Blog – Page 401 – New Product Development

Aircraft Ailerons Industry to Reach USD 1,703.5 Million by 2034 with 13.8% CAGR Growth | FMI Reports

Aircraft Ailerons Market — Aircraft Ailerons Industry

The global aircraft aileron industry is expected to reach USD 467.6 million in 2024, with a projected growth rate of 13.8% CAGR over the forecast period, leading to a value of USD 1,703.5 million by 2034.

Ailerons, essential control surfaces located on aircraft wings, are crucial for managing an aircraft’s roll and lateral movement during flight. They play a key role in maintaining stability, maneuverability, and overall control of the aircraft.

With the growing demand for air travel globally, aircraft production has surged, leading to an increased need for critical components like ailerons. The incorporation of advanced technologies, such as fly-by-wire systems, and the use of lightweight materials in aileron manufacturing are expected to boost the efficiency, performance, and functionality of these systems. Additionally, the aviation industry’s focus on fuel efficiency is driving the adoption of lightweight aerospace materials for ailerons, as reducing aircraft weight directly improves fuel economy.

Key Takeaways:

The complex structure of older aircraft deters the integration of fly-by-wire technology. This aspect will likely stymie the growth of the aircraft ailerons market.
The aircraft ailerons market in the Asia Pacific region will be driven by the healthy growth of the aviation industry due to greater air traffic.
The rise of new operational airports in India bodes well for the Asia Pacific aircraft ailerons market.
North America will account for the largest share of aircraft ailerons market size owing to the early adoption of fly-by-wire technology.

“Swift expansion of the aviation industry coupled with increasing demand for lightweight aircraft parts is expected to supplement the global growth of the aircraft ailerons market over the forecast period,” – says an FMI analyst.

Competitive Landscape

The involvement of several domestic and international players creates a competitive environment for the aircraft ailerons market. Many of these key participants are focusing on organic growth strategies like the release of new products, product approvals, acquiring patents, and other such tactics. Some of the other market players utilize inorganic strategies such as mergers, acquisitions, and partnerships to strengthen their market position.

Asian Composites Manufacturing (ACM), Saab AB, Turkish Aerospace Industries (TAI), Sealand Aviation Ltd., Boeing, ShinMaywa Industries, and Zenith Aircraft Company, among others are some of the major players in the aircraft ailerons market profiled in the full version of the report.

In-Depth Market Analysis: A Complete Report

More Insights into Aircraft Ailerons Industry

FMI offers an unbiased and detailed analysis of the global aircraft ailerons market, providing historical data from 2015 to 2020 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of aircraft type, wing type, material type, ailerons type, and region.

Based on region, the aircraft ailerons market in North America is expected to dominate the global marketplace with the ownership of the largest market share during 2022-2032. The target market in this region was largely influenced by the early adoption of fly-by-wire technology across Canada and the United States. The continuous growth of the tourism industry, evolving aviation sector, and the new-age needs of the consumers are certain factors that further aid the growth of the aircraft ailerons market in North America. Besides, the Asia Pacific region will also present notable growth in the aircraft ailerons market during 2022-2032.

Overall, the constant progress witnessed in the aviation sector along with the growing demand for lightweight aircraft components as well as narrow-bodied aircraft will fuel the growth of the aircraft ailerons market during the forecast period.

Key Segmentations

By Aircraft Type:

Commercial Aircraft
Passenger Aircraft
Logistics Aircraft
Military Aircraft
Combat Aircraft
Non-Combat Aircraft

By Wing Type:

High Wing
Low Wing
Mid Wing

By Material Type:

Composite Materials
Thermoplastic Materials
Thermoset Materials
Metals

By Ailerons Type:

Single Acting Ailerons
Frise Ailerons
Wingtip Ailerons
Differential Ailerons

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fermented Feed Market Advancing Animal Nutrition through Fermentation Technology

According to Future Market Insights’ latest report, the global fermented feed market will reach a value of USD 19.9 billion in 2024. Over the next decade, global sales of fermented feeds are expected to surge at a Compound Annual Growth Rate (CAGR) of 7.8%, reaching USD 42.1 billion by 2034.

Several factors are poised to drive the growth of the fermented feed market during the assessment period. These include the thriving livestock industry, rising demand for animal protein, increasing awareness of the benefits of fermented feed, and the growing need for high-nutritional feeds.

Farmers worldwide are progressively recognizing the health advantages of fermented feed, such as improved digestibility and enhanced nutrient content. This awareness is anticipated to be a significant catalyst for market growth through 2034.

The increasing global demand for animal protein, driven by population growth and evolving lifestyles, is creating a surge in demand for fermented feed. This presents an opportunity for farmers to meet the rising need for animal protein effectively.

Additionally, the adoption of fermented feed contributes to reducing overall feed intake while maintaining or even enhancing nutrient levels, leading to indirect cost savings. Fermented feed also improves feed quality and nutritional content, enhances digestibility, and boosts the immune system, thereby increasing resistance to diseases and bacterial infections.

In poultry, such as chickens, fermented feed promotes higher yield by boosting shell weight, egg size, and meat weight. These advantages are fueling rapid growth in demand for alternative feeds, a trend expected to persist well into 2034.

Key Takeaways from the Market Study:

The global fermented feed market is set to total US$ 19.9 billion in 2024.
Global demand for fermented feeds is forecast to soar at 7.8% CAGR through 2034.
Based on product type, the dry-fermented feed segment is set to account for a value share of 58.3% in 2024.
By livestock, the swine segment will hold a market share of around 41.2% in 2024.
North America is projected to hold a revenue share of 24.7% over the forecast period.
Europe will account for 29.8% of the total fermented feed revenue share over the forecast period.
Sales in China are predicted to surge at 7.6% CAGR from 2024 to 2034.
India will register a CAGR of 8.8% through 2034.

“Players operating in the fermented feed market must focus on the development of species-specific fermented feed benefiting animals at all life stages and reducing the risk of diseases. Manufacturers may benefit from introducing cost-effective products in emerging economies, which are primarily agrarian,” says Nandini Roy Choudhury, Client Partner at Future Market Insights.

Who is Winning?

The fermented feed market has a diverse and dynamic competitive landscape. Lallemand Animal Nutrition, DSM (Biomin), Alltech, Cargill, Chr. Hansen. Archer Daniels Midland Company (ADM) and Lesaffre (Phileo) are key players listed in the report.

These companies are continuously looking to upgrade their portfolios by launching enhanced formulations. They also implement strategies like advertisements, acquisitions, partnerships, agreements, collaborations, and mergers to gain a competitive edge in the market.

Recent Developments in Fermented Fodder/Feed Market

In 2024, Wageningen University & Research and Schothorst Feed Research started a collaboration to enhance the utilization of fermented fodder/feed in poultry and swine feed formulation. In these initiatives, they are exploring fermentation technology with the upcycling of raw materials into digestible ingredients.
In 2022, China-based New Hope Feed Co., Ltd launched a new fermented fodder/feed production line with an annual capacity of 20,000 tons. The company already has a production plant in China with an annual capacity of 300,000 tons.

Key Companies Profiled

Lallemand Animal Nutrition
DSM (Biomin)
Alltech
Cargill
Chr. Hansen
Archer Daniels Midland Company (ADM)
Novus International
Provimi
AB Vista
Lesaffre (Phileo)

Market Segmentation of Fermented Feed Products

By Product Type:

Wet Feed
Dry Feed

By Livestock:

Poultry
Swine
Cattle
Aquaculture
Pets (Dogs, Cats)

By Fermentation Process:

Batch Fermentation
Continuous Fermentation
Aerobic Fermentation
Anaerobic Fermentation

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Children’s Health Supplement Market Supporting Growth and Immunity in Younger Generations

In its latest report, Future Market Insights (FMI) projects the global children’s health supplement market to witness significant growth over the next decade. The market is expected to surge from a valuation of US$ 2,520.1 million in 2024 to an impressive US$ 3,985.4 million by 2034, reflecting a robust CAGR of 4.7%. This upward trajectory is primarily driven by rapid urbanization, particularly among working mothers, and the increasing awareness of the health benefits of children’s supplements.

Drivers of Market Growth

The growing number of women in the workforce is leading to a greater reliance on commercial baby health supplements. This trend is fueled by the demand for easily accessible and nourishing baby food options, such as children’s health supplements. Parents are increasingly recognizing the potential health benefits of these supplements, viewing them as viable alternatives to traditional nursing.

Additionally, the popularity of ready-to-feed products and the availability of various health supplements, including powder infant formulas and dietary foods, are significantly contributing to market growth. The rising demand for children’s health supplements made with purified protein is anticipated to be a key factor propelling the market forward by 2034. Moreover, substantial investments by key companies to develop high-quality supplements and innovations in supplement formulations are further augmenting market expansion.

Historical Trends and Future Projections

The global sales of children’s health supplements have seen steady growth, driven by the popularity of multivitamin and mineral supplements designed to fill nutritional gaps in children’s diets. Emphasis on essential nutrients such as vitamin D, calcium, iron, omega-3 fatty acids, and probiotics has been significant in addressing common deficiencies.

Market Dynamics and Emerging Opportunities

E-commerce is transforming the distribution landscape of children’s health supplements, making it easier for customers to access a wide range of products online. This convenience, coupled with an increasing number of parents adopting children worldwide, is expected to boost the market globally.

Leading companies are now offering personalized supplements tailored to children’s specific nutritional needs based on age, diet, and health goals. Brands that provide evidence-based information and maintain transparency in their sourcing and manufacturing processes are gaining the trust of parents seeking reliable supplements for their children.

Regional Market Outlook

The global market is dominated by regions like North America, Europe, Asia-Pacific (APAC), Middle East, and Africa. The United States is set to remain at the forefront, with its market valuation projected to reach US$ 1,054.8 million by 2034. Other significant markets include China (US$ 204.7 million) and Germany (US$ 169.8 million).

India: A Key Market

In India, the growing number of companies and high investments in research and development efforts are propelling market growth. Rapid urbanization and increased disposable income are leading parents to seek supplements to fill nutritional gaps in their children’s diets.

China: Rising Disposable Income

In China, increasing disposable incomes among families are enabling greater investment in children’s health supplements. The government’s initiatives to promote child health and nutrition are also contributing to market growth.

Japan: Preference for Ready-to-eat Products

Japan’s preference for convenient, ready-to-eat products is driving market growth, with companies focusing on clean-label manufacturing and innovative marketing techniques.

Competitive Landscape

Leading companies in the children’s health supplement market are pursuing strategic alliances, partnerships, and innovative product development to meet the growing demand. Key players include Nestlé S.A., Abbott Laboratories, Pfizer Inc., Reckitt Benckiser Group plc, Sanofi S.A., The Nature’s Bounty Co., Bayer AG, Himalaya Wellness Company, Church & Dwight Co. Inc., and Mead Johnson Nutrition Company.

Recent Developments

BASF partnered with Sinopec to expand its Verbund site in Nanjing, China.
Danone Early Life Nutrition introduced a new infant formula mimicking mother’s milk structure in China.
Nestle’s Gerber received clean-label certifications from a renowned non-profit clean-label project.

Market Segmentation of Children’s Health Supplement Products

By Product Type:

Vitamin and Minerals
Protein
Omega-3
Prebiotics & Probiotic Supplements
Other

By Application:

Infant Milk
Snacks
Protein Drinks
Bar
Others

By Age Group:

Infants
Children
Adolescents

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Food and Grocery Retail Market Adapting to Consumer Preferences in a Dynamic Retail Landscape

The current valuation of the food and grocery retail market is US$ 12.4 trillion by 2024. The market valuation is estimated to be US$ 17.1 trillion by 2034, projected at a CAGR of 3.3%.

Growing awareness about health and wellness has spurred demand for organic, natural, and health-conscious food products. Retailers catering to these preferences are experiencing accelerated growth as they offer diverse nutritious options aligning with evolving dietary trends.

In the last five years, the food and grocery retail sector has shown steady growth, achieving a CAGR of 5.3% from 2019 to 2023. This period marked a surge in consumer demand driven by changing preferences, population growth, and the adoption of new shopping behaviors.

Innovation in technology, such as artificial intelligence (AI), data analytics, and the Internet of Things (IoT), propels efficiency and innovation across the food and grocery retail supply chain.

Despite technological advancements, the food and grocery retail market remains susceptible to supply chain disruptions caused by natural disasters, geopolitical tensions, and global health crises.

Intense competition, price wars, and aggressive marketing strategies can exert downward pressure on profit margins and limit growth opportunities for retailers.

Key Takeaways from the Market Study

Based on product type, the fresh food is registered at a CAGR of 3.1% by 2034.
The United States is expected to register at a CAGR of 1.4% by 2034.
The United Kingdom registers significant growth, projected at a CAGR of 1.3% by 2034.
Based on distribution channel, the supermarkets and hypermarkets segment is registered at a CAGR of 2.9% by 2034.

“The modern consumers, especially those with busy lifestyles, prioritize convenience in their shopping experience where the demand has led to the rise of various convenience-oriented solutions such as online grocery shopping, meal kits, and ready-to-eat options in-store, thus pushing the food and grocery retail market to grow,” says Nandini Roy Choudhury, Client Partner at Future Market Insights.

Competitive Landscape

Intense competition drives innovation, price competitiveness, and strategic acquisitions. Players leverage technology and customer-centric strategies to enhance offerings and capture consumers’ evolving preferences. Some of the key developments are:

In January 2020, Walmart introduced Alphabot, a cutting-edge technology to enhance its grocery business. Alphabot streamlined picking, packing, and delivering online grocery orders, enabling Walmart to reinforce its position as America’s leading grocer and provided faster and more efficient service to shoppers.
In September 2023, C&S Wholesale Grocers, LLC (C&S) acquired 413 stores, eight distribution centers, and two offices. These assets became available following the planned merger between Kroger Co. and Albertsons Companies Inc.

Key Companies Profiled

Walmart
Costco Wholesale Corp.
7-ELEVEN, Inc.
Amazon.com Inc.
The Kroger Co.
Target Brands, Inc.
ALDI
AEON Co Ltd
Carrefour CA
Schwarz Gruppe

More Valuable Insights Available

Future Market Insights offers an unbiased global food and grocery retail market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034

To understand market opportunities, the food and grocery retail market is segmented based on Product (Fresh Food, Frozen Food, Food Cupboard, Beverages, Cleaning & Household, Others), Distribution Channel (Supermarkets & Hypermarkets, Convenience Stores, Departmental Stores, Online) and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

Key Segments

By Product:

Fresh Food
Frozen Food
Food Cupboard
Beverages
Cleaning & Household
Others

By Distribution Channel:

Supermarkets & Hypermarkets
Convenience Stores
Departmental Stores
Online

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Food Fortification Market Addressing Nutritional Deficiencies through Enriched Food Products

The food fortification market size is to be valued at US$ 106.7 billion by 2024. The market valuation is estimated to be US$ 286 billion by 2034, projected at a CAGR of 10.4%.

The food fortification market stands as a beacon of innovation and public health, leveraging fortified foods and beverages to address nutritional deficiencies and enhance overall well-being and imposes marketing strategies for promoting fortified food products to health-conscious consumers.

A surge in awareness of malnutrition and its impact on public health has spurred government initiatives and industry collaborations to fortify staple foods with essential nutrients. Consumer demand for functional foods and personalized nutrition solutions has fueled innovation in fortification techniques and product formulations, driving market expansion and diversification.

Food Fortification industry also faces challenges and opportunities for fortifying plant-based alternatives. Regulatory complexities and inconsistencies across different regions pose hurdles for market players, requiring compliance efforts and adaptability to navigate varying regulatory landscapes.

Consumer skepticism and misinformation regarding fortified foods may hinder adoption rates, highlighting the importance of education and transparency in fortification initiatives.

Opportunities lie in innovation, education, and expanding market reach to underserved populations, while threats include regulatory hurdles, competitive pressures, and misinformation about fortified foods.

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 106.7 billion
Projected Market Valuation in 2034	US$ 286 billion
Value-based CAGR 2024 to 2034	10.4 %
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ billion
Key Market Segments Covered	By Type: Proteins & Amino Acids Vitamins Lipids Prebiotics & Probiotics Carbohydrates Minerals Others By Process: Drum Dying Dusting By Application: Infant Formula Dairy & Dairy-Based Products Cereals & Cereal-Based Products Fats & oils Beverages Dietary Supplements Others By Region: North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain	Italy Russia Poland Czech Republic Romania India Bangladesh Australia	New Zealand China Japan South Korea GCC countries South Africa Israel

Key Takeaways from the Market Study

Based on the type, the proteins and amino acids segment is registered at a CAGR of 10.2% by 2034.
The United States is expected to register at a CAGR of 10.7% by 2034.
The United Kingdom registers significant growth, projected at a CAGR of 11.7% by 2034.
Based on process, the drum dying segment is registered at a CAGR of 10% by 2034.

“The ascending prevalence of malnutrition and related health concerns globally. As the driver underscores the importance of fortification initiatives in combating malnutrition and promoting public health, propelling demand for fortified foods and beverages across various demographics and geographical regions of the industry,” says Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.).

Competitive Landscape

The food fortification ecosystem boasts a competitive landscape characterized by multinational corporations like Nestlé, Kellogg’s, and General Mills alongside regional players.

Intense competition drives innovation and collaboration, with a focus on expanding product portfolios and meeting diverse consumer preferences for fortified foods and beverages.

Some of the key developments are:

In 2021, Evolve BioSystems invested in Cargill and Manna Tree to advance its pioneering probiotic technology aimed at bolstering infant gut health. This partnership fueled research and development efforts in California, with a primary focus on optimizing the health and well-being of newborns through innovative probiotic solutions.
In 2022, FMC Corporation unveiled a groundbreaking technology aimed at revolutionizing the food fortification market. This development introduced a novel approach to fortifying staple foods with essential nutrients, enhancing their nutritional value, and addressing global malnutrition challenges.

More Valuable Insights Available

Future Market Insights offers an unbiased global food fortification market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034.

To understand market opportunities, the food fortification market is segmented based on Type (Proteins & Amino Acids, Vitamins, Lipids, Prebiotics & Probiotics, Carbohydrates, Minerals, Others), Process (Drum Dying, Dusting), Application (Infant Formula, Dairy & Dairy-Based Products, Cereals & Cereal-Based Products, Fats & oils, Beverages, Dietary Supplements, Others), and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Skincare Supplement Market: Empowering Beauty from Within with Functional Ingredients

The global skincare supplement market size is projected to reach US$ 2,780 million in 2024. It is estimated to attain a valuation of around US$ 4,500 million by 2034. The industry is set to witness a CAGR of 8.8% in the forecast period 2024 to 2034.

Functionalities such as skin de-aging, wounds & marks healing, skin brightening, skin hydrating, and acne reduction have captured the demand for effective skincare products and are driving growth. The shift of consumers toward natural and organic alternatives of harmful skincare creams and gels, as well as rising awareness among consumers regarding preventive healthcare, are principal factors for a strong growth rate.

Research & development investments are also a key factor in the growth of the market, as advancements in experimenting and analyzing various formulae have led to the rise of effective supplements sourced from natural ingredients. Out-of-the-box marketing techniques such as regularizing skincare supplements among the masses and reaching out to aging populations around the world point to significant growth for the skincare supplement industry.

Key Takeaways from the Global Skincare Supplement Market Study:

By functionally, the skin de-aging category is projected to remain at the forefront by showcasing a CAGR of 10.9% through 2034.
By sales channel, health & wellness stores are set to exhibit a CAGR of 7.4% from 2024 to 2034.
The form segment is projected to be led by capsules with an 8.8% CAGR through 2034.
India is estimated to witness a CAGR of 6.4% from 2024 to 2034.
The United States is set to rise at a CAGR of 5.3% from 2024 to 2034.

“Increasing use of social media platforms like Snapchat and Instagram is compelling individuals to move toward natural supplements to bolster their skin’s appearance and prevent issues like acne. Hence, leading players are launching unique formulations to attract a large consumer base,” says a lead analyst at Future Market Insights (FMI).

Who is Winning?

Only a new product with exceptional functionality and competitive price can become successful, as the skincare supplement market is a consumer-driven one, with price and effectiveness playing significant roles in the adoption of a product. Companies able to create such products and distribute them effectively to a specific consumer base hold the potential for share expansion.

Some of these leaders of the global skincare supplement market include Amway, HUM Nutrition Inc, Nestle, Meiji Holdings Co Ltd, Shiseido Co Ltd, Unilever, Johnson & Johnson, Perricone MD, and Vitabiotics Ltd. For instance,

Nutrafol, a New York-based skincare brand, introduced Nutrafol Skin in February 2024. It is a new supplement for consumption on a daily basis to prevent acne. The supplement can improve post-acne dark spots and mild-to-moderate acne problems.

Key Segments of Market Report

By Functionality:

Few of the leading functionalities include skin de-aging, skin hydration, acne reduction, wound and mark healing, and skin brightening.

By Form:

In terms of form, the industry is segregated into tablets/pills, capsules, liquid, powder, gummies/chewables, and others.

By Sales Channel:

Hypermarkets/supermarkets, specialty stores, e-commerce, drug stores and pharmacies, health and wellness stores, convenience stores, and departmental stores.

By Region:

Information about key countries across South Asia, East Asia, Oceania, North America, Latin America, Europe, and the Middle East and Africa is provided.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Orthopedic Navigation Systems Market Poised for Significant Growth, Set to Reach USD 13.2 Billion by 2033 with a CAGR of 16.9%

The global orthopedic navigation systems market is on track for substantial growth, with revenues estimated at USD 2.8 billion in 2023 and projected to soar to USD 13.2 billion by 2033, according to a recent report by Future Market Insights. The market is expected to expand at a robust compound annual growth rate (CAGR) of 16.9% over the forecast period.

One of the key drivers of this growth is increasing government investment in research and development for surgical navigation systems. Such initiatives are fueling advancements in technology, improving precision in orthopedic surgeries, and enhancing patient outcomes. However, challenges remain, particularly the high cost of these systems and occasional product recalls, which are likely to hinder market expansion to some extent.

In response, companies in the sector are focusing on raising awareness about the benefits of orthopedic navigation systems among healthcare professionals and patients. In developed markets, manufacturers are actively engaging with local communities and medical professionals through Continuing Medical Education (CME) programs. These initiatives are fostering greater adoption of the technology, as more physicians become familiar with the systems’ capabilities.

In addition to training efforts, orthopedic navigation systems currently available in the market are often sold with six to seven-year warranties, ensuring a steady sales cycle over this period. This, coupled with the growing demand for technology-assisted orthopedic treatments, is expected to support continued market growth throughout the forecast period.

With the ongoing advancements and increasing adoption, the orthopedic navigation systems market is set to redefine how orthopedic surgeries are performed, delivering greater accuracy and improved patient outcomes globally.

Key Takeaways: Global Orthopedic Navigation Systems Market

The global orthopedic navigation systems market is projected to experience significant growth, with revenues expected to increase from USD 2.8 billion in 2023 to USD 13.2 billion by 2033, representing a CAGR of 16.9%.
Key drivers of this growth include increasing demand for minimally invasive surgeries, advancements in technology, and rising healthcare spending.

The United States dominates the market, accounting for a significant share and expected to reach a valuation of USD 5.2 billion by 2033.
The United Kingdom and Japan are also anticipated to experience substantial growth, with projected market values of USD 1.1 billion and USD 539 million, respectively.
South Korea is expected to have a smaller market size but is still projected to grow at a steady pace.

Orthopedic imaging-guided surgical systems are commonly used in various procedures, including complete knee arthroplasty, total hip arthroplasty, anterior cruciate ligament restoration, trauma, and corrective surgeries.

Orthopedic Navigation Systems Market Insights: Access Our Full Report for a Deep Dive into Emerging Trends!

Competitive Landscape:

The key players operating in Orthopedic Navigation Systems Market include Stryker, Medtronic, Johnson & Johnson Services, B. Braun Melsungen AG, Smith + Nephew, OrthAlign, Globus Medical, and Zimmer Biomet.

In February 2021, Brainlab, received FDA clearance for both Cirq and Loop-X Mobile Imaging Robot. Following the CE mark approval, the FDA’s clearance paved the way for Brainlab to enter the U.S. market with the Cirq robotic alignment module for spine procedures, and Loop-X, a fully robotic intraoperative imaging device on the market.
In January 2021, DePuy Synthes received 510(k) FDA clearance for VELYS robotic-assisted solution. It is designed for use with the ATTUNE total knee system.
In November 2020, Stryker, completed the acquisition of Wright Medical, in an attempt to enhance its market position globally in trauma and extremities. It will provide the company with significant opportunities to improve outcomes, advance innovation, and increase patient reach.
In July 2020, Smith + Nephew, publicized the introduction of the RI.HIP Navigation for Total Hip Arthroplasty (THA). This device received 510(k) clearance from the U.S. FDA and CE Mark certification for THA.

Market Segments Covered in Orthopedic Navigation Systems Market Analysis

By Application:

Knee
Hip
Spine

By Technology:

Electromagnetic
Optical
Other Technologies

By End Use:

Hospitals
Ambulatory Surgery Centers

By Region:

North America
Latin America
Europe
APAC
Middle East and Africa(MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Chemotherapy-Induced Oral Mucositis Industry

Fungal Staining Reagent Industry

Europe Platelet Rich Plasma (PRP) Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Ulcerated Necrobiosis Lipoidica Management Market to Reach USD 7.9 Billion by 2033, Fueled by Advancements in Treatment and Diagnostics: FMI Study

The global market for ulcerated necrobiosis lipoidica management is set to witness substantial growth in the coming years, with an estimated market valuation of USD 4.4 billion in 2023. It is projected to reach USD 7.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.03% during the forecast period. The growth is primarily driven by innovations in diagnostic techniques, including magnetic resonance imaging (MRI), along with the increasing number of drug approvals and new treatment options emerging in the market.

Necrobiosis lipoidica, a rare skin condition associated with ulceration, has been a major focus for medical research and treatment development. As advanced diagnostic methods become more accessible, the ability to diagnose this condition early and accurately has significantly improved. This, in turn, is expected to accelerate the demand for effective treatments and interventions in the market.

One of the most prominent treatment approaches currently being adopted is photochemotherapy (PUVA therapy) and photodynamic therapy, which are expected to dominate the treatment landscape for ulcerated necrobiosis lipoidica. These therapies are gaining traction due to their efficacy in managing the condition, driving market growth further.

In addition, the global market is experiencing a surge in drug development and an increasing number of drugs undergoing clinical trials. This shift toward biological and technological advances in the treatment of ulcerated necrobiosis lipoidica will continue to play a crucial role in market expansion. The introduction of new drugs will not only improve treatment outcomes but also address the significant unmet needs in the market, including the lack of clinically proven treatments.

However, the market faces challenges, particularly the rising economic burden associated with ulcerated necrobiosis lipoidica treatment. The direct and indirect costs of long-term treatment and the absence of universally effective therapies highlight the need for innovative solutions. This gap presents significant opportunities for market players to develop new drugs aimed at addressing resistant bacteria and reducing treatment costs, thus paving the way for further growth.

Regulatory approvals will also play a key role in boosting market dynamics. A notable example is the approval of Baxdela (delafloxacin) by the United States Food and Drug Administration (FDA) in June 2017. Baxdela, a fluoroquinolone antibiotic, is used for severe bacterial skin infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA), and is expected to provide a valuable therapeutic option for ulcerated necrobiosis lipoidica patients.

As the market continues to expand, ongoing developments in treatment and diagnostics, coupled with the growing demand for effective solutions, will drive the growth of the global ulcerated necrobiosis lipoidica management market, positioning it for significant advancements over the next decade.

Key Takeaways:

North America is expected to dominate the industry while reaching market share of around 41% by end of the forecast period.
The market in Asia Pacific is projected to account for 32.8% market share by end of the projected period.
By treatment type, ‘UVA1 Phototherapy’ is projected to account for 31% market share by end of the forecast period.
Hospitals are expected to dominate the market by distribution channel, with a market share of 71% by 2033.

“Development of new clinically proven and effective drugs coupled with increasing healthcare expenditure is going to drive the treat market of Ulcerated necrobiosis lipoidica in the forecast period”- Comments an FMI Analyst

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Competitive Landscape:

The Ulcerated Necrobiosis Lipoidica Management Market is intensely competitive and consists of numerous key market players. These key players are developing novel delivery systems for treating ulcerated necrobiosis lipoidica. This is estimated to fuel Ulcerated Necrobiosis Lipoidica Management Market. The key players in this market are: Astellas Pharma, Vibcare Pharma, Pfizer, Manus Aktteva Biopharma LLP, Mylan Pharmaceuticals Inc., Upsher-Smith Laboratories, Novartis, Sanofi, Merck, GlaxoSmithKline.

Key industry players are inclined on adoption of inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to strengthen their product portfolio. This is anticipated to fuel the global Ulcerated Necrobiosis Lipoidica Management Market.

In June 2022, Basilea Pharmaceutica Ltd declared positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in treating adult patients with bacterial bloodstream infections caused by Staphylococcus aureus.
In January 2022, Paladin Labs Inc., which is a subsidiary of Endo International PLC announced the launch of ‘Xydalba’ (dalbavancin for injection), a 30-minute intravenous therapy for chronic bacterial skin structure infections that can be administered as a single- or two-dose.
On July 7, 2021, Melinta Therapeutics, a pharmaceutical company, announced about launch of its product ‘KIMYRSA’. This drug is a lipoglycopeptide antibiotic that offers a complete course of treatment for chronic bacterial skin and skin structure infections including ulcerated necrobiosis lipoidica. This drug is effective in a single dose of 1200mg injection.

Key Segments Profiled in the Ulcerated Necrobiosis Lipoidica Management Industry Survey:

By Treatment:

Skin Grafting
Photodynamic Therapy
UVA1 Phototherapy
Topical Psoralen-UVA Therapy
Drugs
- Antimalarial Agents
- Antitubercular Agents
- Immunosuppressive Agents
- Hemorrheologic Agents
- Fumaric Acid Esters
- Calcineurin Inhibitors
- Corticosteroids

By End User:

Hospitals
Specialty Clinics
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Specialty Control Plasma Industry

Self-urinary Infection Testing Industry

Antibacterial Haemostatic Gels Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Retinal Vein Occlusion Treatment Market Set to Double in Value USD 4.7 Billion by 2033 at a 5.9% CAGR

The global retinal vein occlusion treatment market is on the brink of remarkable growth, with its valuation projected to rise from USD 2.3 billion in 2023 to USD 4.7 billion by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 5.9%, highlighting the increasing demand for effective treatments for this common retinal vascular disease among older adults.

RVO, a significant cause of vision loss, predominantly affects individuals over the age of 65. As the global population continues to age, the incidence of RVO is expected to surge, driving the demand for advanced therapeutic options. Key players in the market are capitalizing on this trend by scaling up the production of corticosteroid drugs, which are essential in managing the inflammatory aspects of the condition and reducing associated edema.

Anti-vascular endothelial growth factor (anti-VEGF) medications such as Lucentis, Avastin, and Eylea are frequently used in treating BRVO cases with neovascularization or macular edema. These treatments are critical in managing the condition and improving patient outcomes.

The market is also benefiting from increased approvals of medications for RVO treatment. Notably, in September 2021, the FDA approved Byooviz (ranibizumab-nuna), the first biosimilar drug developed by Samsung Bioepis, for treating macular degeneration and other eye diseases, including RVO. This landmark approval is expected to drive significant growth in the industry.

Regional Market Insights:

North America held a substantial share of the global RVO market in 2022, owing to various factors such as advanced healthcare facilities, a high prevalence of eye disorders, cutting-edge technology, and an increasing aging population. The region’s robust infrastructure and high healthcare expenditure have been pivotal in supporting market growth.

Looking ahead, the Asia Pacific region is projected to experience the fastest growth, with a CAGR of 6.5% from 2023 to 2033. The rising prevalence of eye conditions, particularly in countries like China, Singapore, Indonesia, and other Southeast Asian nations, coupled with increasing healthcare spending, is expected to fuel market expansion in this region.

As the global population ages and the prevalence of retinal vein occlusion rises, the market for RVO treatments is set for substantial growth. Continued advancements in medical treatments and increased drug approvals will play a critical role in addressing this condition and improving the quality of life for affected individuals.

Key Takeaways from the Market Study:

Global retinal vein occlusion treatment market to reach a valuation of US$ 4.7 billion in 2033
East Asia retinal vein occlusion market is expected to expand at a CAGR of 6.5%.
From 2018 to 2022, sales increased significantly at a CAGR of 5%.
The random-effects gathered likelihood of RVO in Europeans over the age of 55 was 0.7%, according to a 2018 Pubmed report.
The total number of affected people in the EU is expected to nearly double, from 900,000 in 2018 to 1.1 million in 2050.

“Players in the retinal vein occlusion treatment domain are increasing their capacity to produce corticosteroid drugs, which can help combat the inflammatory factors that cause edema. Healthcare professionals, on the other hand, are becoming increasingly skilled in focal laser therapy,” says FMI’s analyst.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Market Competition:

Key players in the retinal vein occlusion treatment market are AbbVie, Roche, Regeneron Pharmaceuticals, Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Kodiak Sciences Inc., Chugai Pharmaceuticals, and Novartis AG among others.

Novartis affirmed highly supportive for the initial interpretable Phase III findings of a clinical study investigating the effectiveness and protection of Beovu in December 2020. Beovu by Novartis placed Regeneron’s anti-VEGF Eylea, one of the renowned treatments for diabetic macular edema, in direct competition.
Roche is presently performing Phase III trials to examine the effectiveness and security of Faricimab in sick people with macular edema secondary to BRVO and CRVO, with the drug anticipated to be approved by 2023 based on the findings.

Key Segments Profiled in the Retinal Vein Occlusion Treatment Industry Survey:

By Drug Class:

Ranibizumab
Dexamethasone
Aflibercept
Bevacizumab

By Type:

Central Retinal Vein Occlusion
Branch Retinal Vein Occlusion

By Diagnosis:

Optical Coherence Tomography
Fundoscopic Examination
Fluorescein Angiography

By End User:

Hospitals
Research and Academics
Specialty Clinics

By Region:

North America
Europe
East Asia
South Asia
Oceania
Latin America
Middle East and Africa (MEA)

𝖤𝗑𝗉𝗅𝗈𝗋𝖾 𝖥𝖬𝖨’𝗌 𝖱𝖾𝗅𝖺𝗍𝖾𝖽 𝖮𝗇𝗀𝗈𝗂𝗇𝗀 𝖢𝗈𝗏𝖾𝗋𝖺𝗀𝖾 𝗈𝗇 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖬𝖺𝗋𝗄𝖾𝗍 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖣𝗈𝗆𝖺𝗂𝗇:

Submucosal Injections Industry

Wet Wipes Canister Industry

Enzyme Substrates Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Hyaluronic Acid Personal Care Products Market Poised for Significant Growth USD 7.36 Billion by 2033

In 2033, the global market for hyaluronic acid personal care products is expected to reach USD 7.36 billion, up from USD 3.26 billion in 2023. This market is expected to register an 8.5% CAGR over the next few years, due to growing concerns about the appearance of aging populations.

It is easy to purchase these products online and through other retail channels, such as beauty salons, pharmacies, supermarkets, and specialty stores, without requiring a prescription. Hyaluronic acid improves the appearance of skincare products by reducing flaking and restoring suppleness to damaged or dry skin.

The use of hyaluronic acid, for instance, can reduce wrinkles, plump up the skin, and improve skin texture overall. Furthermore, the product offers moisture-retaining film properties, anti-wrinkle, anti-irritation properties, nutrition delivery, and free radical scavenging properties. Due to these properties, cosmetic-grade hyaluronic acid is also becoming increasingly popular in skincare, makeup, cleansing, and hair care.

Key Takeaways from Market Study:

The hyaluronic acid personal care products market is expected to record a CAGR of 8.5% over the forecast period.
According to estimates, the market in North America is likely to remain strong throughout the length of the forecast period.
In terms of product, the serum segment accounts for a significant share of the market, since they are more effective at penetrating the skin.
China holds a 40% share of the Asia Pacific market and is projected to expand at a CAGR of over 8.5%.

Enhanced Market Demand! Discover Thorough Trends and Insights in Our Complete Report!

Competitive Landscape:

Several prominent companies dominate this market, including Shiseido Co., Ltd., CeraVe, L’oréal Paris, La Roche Posay, Johnson & Johnson Consumer Inc. (Neutragena), SkinCeuticals, The Ordinary (Deceim Beauty Group, Inc.), Heraux (Carthronix), Innisfree (Amorepacific US, Inc.), Saro De Rúe, Beautiful Korea and others.

Several domestic and international manufacturers are present in the market, and they are continually investing in research and development, making the market highly fragmented. It is common for companies to innovate their products and collaborate with celebrities and social media influencers to gain more customers.

Manufacturers of these products can gain a larger share of the market, expand their product portfolios, and expand their geographical reach by engaging in these activities. By partnering with other companies, key players can also gain access to new markets and advanced technologies. They can also acquire companies, merge, and diversify their portfolios as well.

Recent Developments:

A freeze-dried hyaluronic acid system that offers clinically proven benefits for the skin was introduced by Saro De Re in January 2021.
In March 2021, Royal DSM, a global science-based company focused on nutrition, health, and sustainability, launched three forms of hyaluronic acid. HYA-ACT Medium Molecular Weight (MW 1.0-1.3 MDa) enhances skin hydration and strengthens the skin’s protective barrier. HYA-ACT XS Molecular Weight (MW 37-56 kDa) pumps out fine lines and wrinkles and locks in moisture for an even greater hydration boost and calms reddened skin, while HYA-ACT Small Molecular Weight (MW 200-400 kDa) locks in moisture for an even greater hydration boost and calms reddened skin.
In February 2020, Seikagaku Corporation, Japan-based pharmaceutical research and development company announced that it had acquired Dalton Chemical Laboratories Inc, a Canadian drug manufacturer. As a result of this acquisition, Seikagaku is able to strengthen its market position, as well as expand its research and development operations.

Key Segments:

By Product:

Skin Creams
Skin Lotions
Toner
Serum
Moisturize

By Price:

High/Premium
Medium
Low

By Application:

Dermal Fillers
Ophthalmic

By Distribution Channel:

Supermarket/Hypermarket
Specialty Stores
Company Owned Websites
Online Retailing

By Region:

North America
Latin America
Europe
The Middle East and Africa
East Asia

Photoacoustic Microscopy Industry

Rapid Hepatitis Testing Industry

Prefilled Hemostasis Agents Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: